Search results
HEALTHY LIVING: Men’s Health Month: Understand your risk for lung cancer | Siloam Springs...
Northwest Arkansas Democrat Gazette· 4 hours agoAccording to the American Lung Association, more men than women are diagnosed with lung cancer each...
Colon cancer: Symptoms, causes and treatment
The Telegraph via Yahoo News· 5 days agoWhen my father was diagnosed with colon cancer, he didn’t have any symptoms. It was luck that led him to the doctor’s office for the screening that saved...
City of Hope’s new blood test for lung cancer will mean more early detections
Los Angeles Daily News· 5 days agoTo test for lung cancer, a person needs to get low-dose computed tomography screening, more commonly...
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 2 days agoPhase III trial results for a new drug targeting advanced lung cancer have just been reported, with...
The Biggest Risk Factor for Bladder Cancer Has Nothing to Do With Pee, Diet, or Genes
AOL· 16 hours agoBladder cancer is most common in older men, but anyone can get it. Smoking is the biggest risk factor for bladder cancer because carcinogens in the blood ...
SSM Health Medical Minute: Lung cancer screening as critical as mammogram, colonoscopy
KTVI via Yahoo News· 6 days agoLung cancer is the leading cause for cancer-related death in the United States. Screening before...
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 1 day agoUse (CHMP) of the European Medicines Agency (EMA) has recommended approving AstraZeneca's Tagrisso,...
‘Whew. He didn’t say avoid Diet Coke’: Cancer doctor shares the 5 things he ‘would never do’
The Daily Dot· 6 hours agoA popular oncology dietician just took her followers with her to the grocery store to show them...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 1 day agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 20 hours agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small cell lung